Barton, the discussant, took a cautionary view, saying that there are some things to consider before going out and telling patients to consider acetyl-carnitine for their peripheral neuropathy. It was unclear from the results reported whether the two treatment groups were well balanced and what criteria were used to define improvement for the secondary outcomes, she noted
Instead, GLP1 therapies make moderation feel effortless
You can read the abstract of this article at In a Phase 3 trial involving 1879 individuals with type 2 diabetes (T2D) on metformin, Tirzepatide (TZP) at doses of 5 and 15 mg demonstrated substantial improvements in HbA1c and weight reduction compared to 1 mg of semaglutide (SEMA)
However, the affinity ratios are not identical
Data compiled in Britain by Drinkaware and KAM found that some GLP-1 users say they drink less when they go out and visit restaurants less often overall
Rutter GA, Da Silva Xavier G, Leclerc I